Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy [NA]
This clinical trial update describes a study comparing stapler reinforcement patches to standard staplers in gastrojejunostomy for gastric c…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Large Language Models Assist in Tumor MDT [NA]
A clinical trial is recruiting to test the use of large language models to assist multidisciplinary tumor board discussions across multiple …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
This Martinique-based clinical trial is recruiting to study the prevalence of Helicobacter pylori infection and gastric cancer in the West I…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer [Phase 2]
A Phase 2 clinical trial update evaluating total neoadjuvant therapy with short-course radiation therapy for gastric cancer, currently not y…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer [NA]
A clinical trial comparing proximal gastrectomy with pyloroplasty to esophagogastric anastomosis for gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Changes Associated With H. Pylori and Gastric Carcinogenesis
This clinical trial update notes ongoing recruitment for a study examining the relationship between Helicobacter pylori infection and gastri…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy [EARLY_Phase 1]
This is a pilot early-phase imaging trial evaluating the HER2-targeted PET tracer [68Ga]Ga-ABY-025 in patients undergoing HER2-targeted ther…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 4]
Phase 4 clinical trial evaluating iparomlimab and tuvonralimab with SOX chemotherapy as first-line treatment for unresectable HER2-negative …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection [Phase 2]
Phase 2 trial assessing the imaging tracer 18F-FAPI-74 for cancer detection across multiple indications; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
This clinical trial update notes a Phase 1 study of BAL0891 by SillaJen in patients with advanced solid tumors, including triple-negative br…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 study evaluating an [18F]FPyQCP PET imaging agent targeting fibroblast activation protein across colorectal cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
An ongoing clinical study in Algeria is investigating the epidemiology, clinical features, diagnostics, and treatment of gastric cancer; the…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: PROGAIN Trial in Gastric Cancer Surgery [Phase 3]
PROGAIN is a Phase 3 clinical trial evaluating gastric cancer surgery, currently recruiting at Soonchunhyang University Hospital.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours [Phase 1]
A Phase 1 trial evaluating intratumoral IVX037 in patients with advanced or metastatic solid tumours; the study is currently recruiting, foc…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial in China evaluating sintilimab plus chemotherapy versus chemotherapy alone as adjuvant therapy for gastric or gastr…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Real-World, Single-Arm Study Protocol of Disitamab Vedotin in Combination With Immunotherapy and Multimodal Radiation Therapy for HER2-Positive Advanced Gastric Cancer: After Second-Line Treatment Failure
This document outlines a real-world, single-arm study protocol evaluating disitamab vedotin in combination with immunotherapy and multimodal…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 [Phase 1]
Phase 1/1b trial evaluating RNDO-564 as a single agent or in combination with pembrolizumab in bladder cancer and nectin-4–associated solid …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer [Phase 1]
Phase 1 clinical trial evaluating nivolumab with or without relatlimab before chemoradiation in patients with gastric or esophageal cancers;…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body [Phase 3]
A Phase 3 trial is evaluating whether adding radiotherapy to standard chemotherapy improves outcomes for patients with metastatic esophageal…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing [Phase 4]
Phase 4 clinical trial evaluating esomeprazole plus sucralfate for healing ulcers after endoscopic submucosal dissection in gastric neoplasm…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 first-in-human study of IPH5301, an anti-CD73 antibody, given alone or with chemotherapy and trastuzumab, in patients with advance…